Staphylococci.
Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to beta-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci.
Department of Clinical Microbiology and Infection Control, University Hospital Birmingham NHS Foundation Trust, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.
A L
AL
Casey
P A
PA
Lambert
T S J
TS
Elliott
D024881:Drug Resistance, Bacterial; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D013210:Staphylococcus / Q000187:drug effects* / Q000201:enzymology